{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:23:15Z","timestamp":1779888195677,"version":"3.53.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.biopha.2012.11.005","type":"journal-article","created":{"date-parts":[[2012,11,23]],"date-time":"2012-11-23T15:48:26Z","timestamp":1353685706000},"page":"321-328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Synergistic induction of TRAIL-mediated apoptosis by anisomycin in human hepatoma cells via the BH3-only protein Bid and c-Jun\/AP-1 signaling pathway"],"prefix":"10.1016","volume":"67","author":[{"given":"Cheng-Yun","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Hyun","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Ho","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Woo","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HongDe","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HongMin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gi Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wun-Jae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hyun","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung Hyun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2012.11.005_bib0005","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI6926","article-title":"Safety and antitumor activity of recombinant soluble Apo2 ligand","volume":"104","author":"Ashkenazi","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.biopha.2012.11.005_bib0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cytogfr.2004.12.001","article-title":"Tumor therapeutics by design: targeting and activation of death receptors","volume":"16","author":"Wajant","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.biopha.2012.11.005_bib0015","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1074-7613(00)80212-5","article-title":"Apo2L\/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5","volume":"12","author":"Kischkel","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2012.11.005_bib0020","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S1074-7613(00)80211-3","article-title":"FADD\/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2","volume":"12","author":"Sprick","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2012.11.005_bib0025","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","article-title":"Identification and characterization of a new member of the TNF family that induces apoptosis","volume":"3","author":"Wiley","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2012.11.005_bib0030","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1053\/jhep.2000.16266","article-title":"Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines","volume":"32","author":"Yamanaka","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2012.11.005_bib0035","first-page":"1498","article-title":"TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells","volume":"36","author":"Kim","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2012.11.005_bib0040","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/hep.20203","article-title":"An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice","volume":"39","author":"Pei","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2012.11.005_bib0045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cbi.2009.03.020","article-title":"Genistein enhances TRAIL-induced apoptosis through inhibition of p38 MAPK signaling in human hepatocellular carcinoma Hep3B cells","volume":"180","author":"Jin","year":"2009","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.biopha.2012.11.005_bib0050","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1016\/S0021-9258(18)95953-3","article-title":"Inhibitors of protein biosynthesis II. Mode of action of anisomycin","volume":"242","author":"Grollman","year":"1967","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopha.2012.11.005_bib0055","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1128\/MCB.17.6.3373","article-title":"Ribotoxic stress response: activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the alpha-sarcin\/ricin loop in the 28S rRNA","volume":"17","author":"Iordanov","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.biopha.2012.11.005_bib0060","doi-asserted-by":"crossref","first-page":"8961","DOI":"10.1074\/jbc.M109391200","article-title":"Transactivation of ErbB2 and ErbB3 by tumor necrosis factor-alpha and anisomycin leads to impaired insulin signaling through serine\/threonine phosphorylation of IRS proteins","volume":"277","author":"Hemi","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopha.2012.11.005_bib0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/neu.10234","article-title":"Selective involvement of the PI3K\/PKB\/bad pathway in retinal cell death","volume":"56","author":"Campos","year":"2003","journal-title":"J Neurobiol"},{"key":"10.1016\/j.biopha.2012.11.005_bib0070","doi-asserted-by":"crossref","first-page":"13985","DOI":"10.1074\/jbc.274.20.13985","article-title":"Trichothecene mycotoxins trigger a ribotoxic stress response that activates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase and induces apoptosis","volume":"274","author":"Shifrin","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopha.2012.11.005_bib0075","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0145-2126(01)00099-6","article-title":"c-Jun N-terminal kinase\/stress-activated protein kinase (JNK\/SAPK) is required for mitoxantrone- and anisomycin-induced apoptosis in HL-60 cells","volume":"26","author":"Stadheim","year":"2002","journal-title":"Leuk Res"},{"key":"10.1016\/j.biopha.2012.11.005_bib0080","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1158\/1541-7786.MCR-06-0433","article-title":"Ribotoxic stress sensitizes glioblastoma cells to death receptor induced apoptosis: requirements for c-Jun NH2-terminal kinase and Bim","volume":"5","author":"Xia","year":"2007","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.biopha.2012.11.005_bib0085","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1124\/jpet.108.149948","article-title":"The protein synthesis inhibitor anisomycin induces macrophage apoptosis in rabbit atherosclerotic plaques through p38 mitogen-activated protein kinase","volume":"329","author":"Croons","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopha.2012.11.005_bib0090","doi-asserted-by":"crossref","first-page":"20593","DOI":"10.1074\/jbc.M211010200","article-title":"Translation inhibitors sensitize prostate cancer cells to apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by activating c-Jun N-terminal kinase","volume":"278","author":"Sah","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopha.2012.11.005_bib0095","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1158\/1535-7163.MCT-07-0278","article-title":"Malignant mesothelioma cells are rapidly sensitized to TRAIL-induced apoptosis by low-dose anisomycin via Bim","volume":"6","author":"Abayasiriwardana","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.biopha.2012.11.005_bib0100","doi-asserted-by":"crossref","first-page":"7330","DOI":"10.1038\/sj.onc.1207995","article-title":"Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase","volume":"23","author":"Nakshatri","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2012.11.005_bib0105","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3858\/emm.2012.44.7.051","article-title":"Parthenolide-induced apoptosis of hepatic stellate cells and anti-fibrotic effects in an in vivo rat model","volume":"44","author":"Kim","year":"2012","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.biopha.2012.11.005_bib0110","doi-asserted-by":"crossref","first-page":"331","DOI":"10.5483\/BMBRep.2012.45.6.249","article-title":"Identification of interacting proteins of retinoid-related orphan nuclear receptor gamma in HepG2 cells","volume":"45","author":"Huang","year":"2012","journal-title":"BMB Rep"},{"key":"10.1016\/j.biopha.2012.11.005_bib0115","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/40901","article-title":"X-linked IAP is a direct inhibitor of cell-death proteases","volume":"388","author":"Deveraux","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2012.11.005_bib0120","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/sj.emboj.7600544","article-title":"XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs","volume":"24","author":"Scott","year":"2005","journal-title":"EMBO J"},{"key":"10.1016\/j.biopha.2012.11.005_bib0125","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1054\/bjoc.2001.1980","article-title":"Differences between human breast cell lines in susceptibility towards growth inhibition by genistein","volume":"85","author":"Dampier","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.biopha.2012.11.005_bib0130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0955-0674(98)80143-9","article-title":"Signal transduction by the c-Jun N-terminal kinase (JNK) from inflammation to development","volume":"10","author":"Ip","year":"1998","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.biopha.2012.11.005_bib0135","doi-asserted-by":"crossref","first-page":"25884","DOI":"10.1074\/jbc.M203039200","article-title":"The p38 and JNK pathways cooperate to trans-activate vitamin D receptor via c-Jun\/AP-1 and sensitize human breast cancer cells to vitamin D(3)-induced growth inhibition","volume":"277","author":"Qi","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopha.2012.11.005_bib0140","doi-asserted-by":"crossref","first-page":"8502","DOI":"10.1158\/0008-5472.CAN-04-2599","article-title":"TRAIL inhibits tumor growth but is nontoxic to human hepatocytes in chimeric mice","volume":"64","author":"Hao","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2012.11.005_bib0145","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.semcancer.2004.04.002","article-title":"The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer","volume":"14","author":"Nachmias","year":"2004","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.biopha.2012.11.005_bib0150","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.4155\/fmc.09.116","article-title":"Targeting inhibitor of apoptosis proteins for therapeutic intervention","volume":"1","author":"Ndubaku","year":"2009","journal-title":"Future Med Chem"},{"key":"10.1016\/j.biopha.2012.11.005_bib0155","doi-asserted-by":"crossref","first-page":"7815","DOI":"10.1158\/0008-5472.CAN-04-3875","article-title":"Protein kinase C. inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis in cancer cells","volume":"65","author":"Shi","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2012.11.005_bib0160","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1182\/blood-2007-05-091504","article-title":"Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5","volume":"111","author":"Carter","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2012.11.005_bib0165","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1158\/1535-7163.MCT-05-0362","article-title":"Acquired resistance to TRAIL-induced apoptosis in human ovarian cancer cells is conferred by increased turnover of mature caspase-3","volume":"5","author":"Lane","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.biopha.2012.11.005_bib0170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0301-0082(99)00042-8","article-title":"JNK and p38 stress kinases-degenerative effectors of signal-transduction-cascades in the nervous system","volume":"61","author":"Mielke","year":"2000","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.biopha.2012.11.005_bib0175","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1476-4598-8-56","article-title":"Photodynamic therapy inhibits P-glycoprotein mediated multidrug resistance via JNK activation in human hepatocellular carcinoma using the photosensitizer pheophorbide a","volume":"8","author":"Tang","year":"2009","journal-title":"Mol Cancer"},{"key":"10.1016\/j.biopha.2012.11.005_bib0180","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/hep.24314","article-title":"Diclofenac inhibits tumor necrosis factor-\u03b1-induced nuclear factor-\u03baB activation causing synergistic hepatocyte apoptosis","volume":"53","author":"Fredriksson","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2012.11.005_bib0185","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/MCB.20.2.575-582.2000","article-title":"c-Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agents","volume":"20","author":"Kolbus","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.biopha.2012.11.005_bib0190","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1128\/MCB.19.1.751","article-title":"Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death","volume":"19","author":"Le-Niculescu","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.biopha.2012.11.005_bib0195","doi-asserted-by":"crossref","first-page":"10023","DOI":"10.1074\/jbc.275.14.10023","article-title":"Regulation of FasL by NF-kappaB and AP-1 in Fas-dependent thymineless death of human colon carcinoma cells","volume":"275","author":"Harwood","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopha.2012.11.005_bib0200","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/sj.bjc.6600612","article-title":"Anisomycin activates JNK and sensitises DU 145 prostate carcinoma cells to Fas mediated apoptosis","volume":"87","author":"Curtin","year":"2002","journal-title":"Br J Cancer"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332212001163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332212001163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:51:56Z","timestamp":1760093516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332212001163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0753332212001163"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2012.11.005","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic induction of TRAIL-mediated apoptosis by anisomycin in human hepatoma cells via the BH3-only protein Bid and c-Jun\/AP-1 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2012.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}